Measurement of hypoxia using invasive oxygen-sensitive electrode, pimonidazole binding and 18F-FDG uptake in anaemic or erythropoietin-treated mice bearing human glioma xenografts

International Journal of Oncology

Volumn 32, Issue 1, 2008, Pages 69-77

  Scigliano, Sonia ^a   Pinel, Sophie ^a,b   Poussier, Sylvain ^a,b   Fouyssac, Fanny ^a   Plenat, Francois ^a   Karcher, Gilles ^a   Chastagner, Pascal ^a  

^a CHU NANCY BRABOIS   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

18F FDG; Glioma xenografts; Hypoxia; Oxygen sensitive probe; Pimonidazole

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; HEMOGLOBIN; PIMONIDAZOLE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD SAMPLING; CONTROLLED STUDY; ELECTRODE; ERYTHROPOIESIS; GLIOMA; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HYPOXIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; OXYGEN CONSUMPTION; OXYGENATION; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME; XENOGRAFT;

EID: 38749109179     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.32.1.69     Document Type: Article

References (47)

1. Becker A, Hansgen G, Bloching M, Weigel C, Lautenschlager C and Dunst J: Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue. Int J Radiat Oncol Biol Phys 42: 35-41, 1998.
2. Hockel M, Schlenger K, Knoop C and Vaupel P: Oxygenation of carcinomas of the uterine cervix: evaluation by computerized 02 tension measurements. Cancer Res 51: 6098-6102, 1991.
3. 2 tension measurements. Cancer Res 51: 3316-3322, 1991.
4. Brizel DM, Rosner GL, Harrelson J, Prosnitz LR and Dewhirst MW: Pretreatment oxygenation profiles of human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 30: 635-642, 1994.
5. 2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 29:427-431, 1994.
6. Collingridge DR, Piepmeier JM, Rockwell S and Knisely JP: Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 53: 127-131, 1999.
7. Nordsmark M, Overgaard M and Overgaard J: Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41: 31-39, 1996.
8. Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L and Hill RP: Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20: 680-687, 2002.
9. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH and Broder GJ: Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14: 831-838, 1988.
10. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U and Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56: 4509-4515, 1996.
11. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR and Dewhirst MW: Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56: 941-943, 1996.
12. Nordsmark M, Loncaster J, Chou SC, et al: Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. Int J Radiat Oncol Biol Phys 49: 581-586, 2001.
13. Stadler P, Becker A, Feldmann HJ, Hansgen G, Dunst J, Wurschmidt F and Molls M: Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 44: 749-754, 1999.
14. 2 histography in patients with advanced head and neck cancer. Radiother Oncol 57: 31-37, 2000.
15. Nordsmark M and Overgaard J: A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 57: 39-43, 2000.
16. Raleigh JA, Dewhirst MW and Thrall DE: Measuring tumor hypoxia. Semin Radiat Oncol 6: 37-45, 1996.
17. Evans SM, Hahn S, Pook DR, et al: Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res 60: 2018-2024, 2000.
18. Varia MA, Calkins-Adams DP, Rinker LH, Kennedy AS, Novotny DB, Fowler WC Jr and Raleigh JA: Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol 71: 270-277, 1998.
19. Arteel GE, Thurman RG, Yates J-M and Raleigh JA: Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer 72: 889-895, 1995.
20. Wijffels KI, Kaanders JH, Rijken PF, et al: Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas. Br J Cancer 83: 674-683, 2000.
21. Raleigh JA, Calkins-Adams DP, Rinker LH, et al: Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res 58: 3765-3768, 1998.
22. Koch CJ, Evans SM and Lord EM: Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]: analysis of drug adducts by fluorescent antibodies vs bound radioactivity. Br J Cancer 72: 869-874, 1995.
23. Varghese AJ, Gulyas S and Mohindra JK: Hypoxia-dependent reduction of 1-(2-nitro-l-imidazolyl)-3-methoxy-2-propanol by Chinese Hamster Ovary cells and KHT tumor cells in vitro and in vivo. Cancer Res 36: 3761-3765, 1976.
24. 2 at the cellular level. Br J Cancer 54: 453-457, 1986.
25. 18F-Fluorodeoxyglucose. Part I Biochemical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol 126: 549-559, 2000.
26. Vaupel P, Kallinowski F and Okunieff P: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465, 1989.
27. Fyles AW, Milosevic M, Pintilie M, Syed A and Hill RP: Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 57: 13-19, 2000.
28. Hill RP, Bush RS and Yeung P: The effect of anaemia on the fraction of hypoxic cells in an experimental tumour. Br J Radiol 44: 299-304, 1971.
29. Becker A, Stadler P, Lavey RS, et al: Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 46: 459-466, 2000.
30. Dunst J, Kuhnt T, Strauss HG, Krause U, Pelz T, Koelbl H and Haensgen G: Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 56: 778-787, 2003.
31. Pinel S, Barberi-Heyob M, Cohen-Jonathan E, Merlin JL, Delmas C, Plenat F and Chastagner P: Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts. Int J Radiat Oncol Biol Phys 59: 250-259, 2004.
32. Pinel S, Chastagner P, Merlin JL, Marchal C, Taghian A and Barberi-Heyob M: Topotecan can compensate for protracted radiation treatment time effects in high grade glioma xenografts. J Neurooncol 76: 31-38, 2006.
33. Raleigh JA, Chou SC, Arteel GE and Horsman MR: Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 151: 580-589, 1999.
34. Raleigh JA, Chou SC, Bono EL, Thrall DE and Varia MA: Semiquantitative immunohistochemical analysis for hypoxia in human tumors. Int J Radiat Oncol Biol Phys 49: 569-574, 2001.
35. Vaupel P, Mayer A and Hockel M: Impact of hemoglobin levels on tumor oxygenation: the higher, the better? Strahlenther Onkol 182: 63-71, 2006.
36. Hardee ME, Arcasoy MO, Blackwell KL, Kirkpatrick JP and Dewhirst MW: Erythropoietin biology in cancer. Clin Cancer Res 12: 332-339, 2006.
37. Bohlius J, Weingart O, Trelle S and Engert A: Cancer-related anemia and recombinant human erythropoietin: an updated overview. Nat Clin Pract Oncol 3: 152-164, 2006.
38. Hardee ME, Kirkpatrick JP, Shan S, et al: Human recombinant erythropoietin (rEPO) has no effect on tumour growth or angiogenesis. Br J Cancer 93: 1350-1355, 2005.
39. Shannon AM, Bouchier-Hayes DJ, Condron CM and Toomey D: Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of lewis lung carcinoma. Br J Cancer 93: 224-232, 2005.
40. Nordsmark M, Loncaster J, Aquino-Parsons C, et al: Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. Radiother Oncol 67: 35-44, 2003.
41. 2-polarography in metastatic head and neck cancer. Eur J Nucl Med Mol Imaging 33: 1426-1431, 2006.
42. Clavo AC, Brown RS and Wahl RL: Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med 36: 1625-1632, 1995.
43. Clavo AC and Wahl RL: Effects of hypoxia on the uptake of tritiated thymidine, L-leucine, L-methionine and FDG in cultured cancer cells. J Nucl Med 37: 502-506, 1996.
44. Burgman P, Odonoghue JA, Humm JL and Ling CC: Hypoxia-induced increase in FDG uptake in MCF7 cells. J Nucl Med 42: 170-175, 2001.
45. Dearling JL, Flynn AA, Sutcliffe-Goulden J, et al: Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. J Nucl Med 45: 101-107, 2004.
46. Pugachev A, Ruan S, Carlin S, Larson SM, Campa J, Ling CC and Humm JL: Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys 62: 545-553, 2005.
47. 18F-Fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res 10: 2245-2252, 2004.